MedTrace Logo

Optimizing Implementation of Long Acting Injectable PrEP

NCT07649551 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-06-16

No results posted yet for this study

Summary

Our goal is to optimize LAI-PrEP implementation within the context of other PrEP methods. Our strategy is flexible to allow pivot to include forthcoming PrEP dosing options should they become available

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Plan-Do-Study-Act

Implementation strategy of conducting cyclical small tests of change using Plan-Do-Study-Act

Sponsors & Collaborators

Principal Investigators

  • Steven A John, PhD, MPH · University of Minnesota

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2027-01-01
Primary Completion
2030-12-31
Completion
2030-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07649551 on ClinicalTrials.gov